Advances in the imaging of gastroenteropancreatic neuroendocrine neoplasms

doi:10.3748/wjg.v28.i26.3008

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 28, Issue 26

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5029)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-9) series, Tables (1-3) series.

Item

Count

PDF

259

WORD

HTML

2623

Figures (1-9)

410

Tables (1-3)

362

Sum=3722

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

201

Download

340

Sum=541

Publishing Process of This Article

Item

Count

Browse

275

Download

491

Sum=766

Jul 14, 2022 (publication date) through Aug 30, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Jul 14, 2022; 28(26): 3008-3026
Published online Jul 14, 2022. doi: 10.3748/wjg.v28.i26.3008

Table 2 Sensitivity of common imaging modalities used in the evaluation of gastroenteropancreatic neuroendocrine neoplasms

Imaging modality	Sensitivity
Transabdominal USG	13%-27% for GEPNEN
Contrast enhanced ultrasound	99% in detecting liver metastases
Endoscopic ultrasonography	82%-93% for PNEN
CECT	63%-82% for PNEN
CE MRI	79% for PNEN
DWI	83% for liver metastases

USG: Ultrasonography; GEPNEN: Gastroenteropancreatic neuroendocrine neoplasms; CECT: Contrast enhanced computed tomography; CE MRI: Contrast-enhanced magnetic resonance imaging; DWI: Diffusion-weighted imaging.

Citation: Ramachandran A, Madhusudhan KS. Advances in the imaging of gastroenteropancreatic neuroendocrine neoplasms. World J Gastroenterol 2022; 28(26): 3008-3026
URL: https://www.wjgnet.com/1007-9327/full/v28/i26/3008.htm
DOI: https://dx.doi.org/10.3748/wjg.v28.i26.3008